NFKBIA and lung disorder: They investigated the functional and clinical impact of human genetic variants in the promoter of NFKBIA, which encodes IκBα, the main negative regulator of NF-κB, highlighting how NFKBIA/IκBα is a central hub in the transcriptional responses of the main childhood lung diseases.